Close

Production & Manufacturing

Astorg to acquire leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG

Astorg and International Chemical Investors Group announce that they have signed a binding agreement whereby Astorg will acquire CordenPharma (“CordenPharma” or the “Company”), a global leading pharmaceutical CDMO (Contract Development & Manufacturing Organisation) with highly differentiated capabilities in Active...

200M COVID Jab Left Over Doses Leads SII Halting Production

As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses. As per Bloomberg, Serum Institute of India (SII) CEO Adar Poonawalla revealed at the India Economic Conclave that they had ceased...

Recipharm secures vaccine manufacturing deal

Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France. The agreement was announced following the successful quality audit and will...

4 Trends Transforming the Never-Normal Future of Manufacturing

2021 Manufacturing Trends If 2020 was the year of disruption, 2021 is the year of adaptation. Download this trend brief to explore ways that manufacturers are adapting to change and evolving to stay competitive. What's Included: Embracing digitization. Liberating data. Balancing...

CapsCanada Launches Liquid-Filled Hard Capsule Manufacturing Service in North America

CapsCanada, a Lyfe Group company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada’s objective is to support the entire manufacturing process, from formulation...

PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing of Ixovex-1

PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and Lonza, a world leader in contract manufacturing, announced their agreement for the process development...

Altimmune Expands AdCOVID Manufacturing Collaboration with Lonza

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read